{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:50:20Z","timestamp":1780375820533,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1144-5","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T20:51:48Z","timestamp":1539204708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-7836","authenticated-orcid":false,"given":"Koichiro","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Toshito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-etsu","family":"Mizoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"1144_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2013.09.006","volume":"109","author":"F Solda","year":"2013","unstructured":"Solda F, Lodge M, Ashley S, et al. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol. 2013;109:1\u20137.","journal-title":"Radiother Oncol"},{"key":"1144_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2017.04.022","volume":"109","author":"T Eriguchi","year":"2017","unstructured":"Eriguchi T, Takeda A, Sanuki N, et al. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer. Lung Cancer. 2017;109:62\u20137.","journal-title":"Lung Cancer"},{"key":"1144_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Marinus AP, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630\u20137.","journal-title":"Lancet Oncol"},{"key":"1144_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/JTO.0000000000000525","volume":"10","author":"Y Shibamoto","year":"2015","unstructured":"Shibamoto Y, Hashizume C, Baba F, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results. J Thorac Oncol. 2015;10:960\u20134.","journal-title":"J Thorac Oncol"},{"key":"1144_CR5","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijrobp.2009.04.023","volume":"75","author":"OK Macdonald","year":"2009","unstructured":"Macdonald OK, Kruse JJ, Miller JM, et al. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Int J Radiat Oncol Biol Phys. 2009;75:950\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR6","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ijrobp.2010.05.016","volume":"79","author":"N Kadoya","year":"2011","unstructured":"Kadoya N, Obata Y, Kato T, et al. Dose-volume comparison of proton radio- therapy and stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;79:1225\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/JTO.0b013e31823529fc","volume":"7","author":"E Roelofs","year":"2012","unstructured":"Roelofs E, Engelsman M, Rasch C, et al. ROCOCO consortium. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. J Thorac Oncol. 2012;7:165\u201376.","journal-title":"J Thorac Oncol"},{"key":"1144_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/JTO.0b013e318288ab02","volume":"8","author":"H Iwata","year":"2013","unstructured":"Iwata H, Demizu Y, Fujii O, et al. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer. J Thorac Oncol. 2013;8:726\u201335.","journal-title":"J Thorac Oncol"},{"key":"1144_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2016.10.022","volume":"122","author":"JY Chang","year":"2017","unstructured":"Chang JY, Zhang W, Komaki R, et al. Long-term outcome of phase I\/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiother Oncol. 2017;122:274\u201380.","journal-title":"Radiother Oncol"},{"key":"1144_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cllc.2015.11.013","volume":"17","author":"Y Hatayama","year":"2015","unstructured":"Hatayama Y, Nakamura T, Suzuki M, et al. Clinical outcomes and prognostic factors of high-dose proton beam therapy for peripheral stage I non-small-cell lung cancer. Clin Lung Cancer. 2015;17:427\u201332.","journal-title":"Clin Lung Cancer"},{"key":"1144_CR11","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.cllc.2013.11.002","volume":"15","author":"A Kanemoto","year":"2014","unstructured":"Kanemoto A, Okumura T, Ishikawa H, et al. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non-small-cell lung cancer. Clin Lung Cancer. 2014;15:e7\u201312.","journal-title":"Clin Lung Cancer"},{"key":"1144_CR12","unstructured":"Particle Therapy Co-Operative Group. \n                    https:\/\/www.ptcog.ch\n                    \n                  . Accessed 18 Aug 2018."},{"issue":"1","key":"1144_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10(1):10.","journal-title":"Control Clin Trials"},{"key":"1144_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijrobp.2016.01.017","volume":"95","author":"H Iwata","year":"2016","unstructured":"Iwata H, Ogino H, Hashimoto S, et al. Spot scanning and passive scattering proton therapy: relative biological effectiveness and oxygen enhancement ratio in cultured cells. Int J Radiat Oncol Biol Phys. 2016;95:95\u2013102.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s13246-016-0456-8","volume":"39","author":"T Toshito","year":"2016","unstructured":"Toshito T, Omachi C, Kibe Y, et al. A proton therapy system in Nagoya proton therapy center. Australas Phys Eng Sci Med. 2016;39:645\u201354.","journal-title":"Australas Phys Eng Sci Med"},{"key":"1144_CR16","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0360-3016(00)01555-8","volume":"49","author":"MF Moyers","year":"2001","unstructured":"Moyers MF, Miller DW, Bush DA, et al. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys. 2001;49:1429\u201338.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR17","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1118\/1.3120288","volume":"36","author":"B Arjomandy","year":"2009","unstructured":"Arjomandy B, Sahoo N, Zhu XR, et al. An overview of the comprehensive proton therapy machine quality assurance procedures implemented at the University of Texas M. D. Anderson Cancer center proton therapy center-Houston. Med Phys. 2009;36:2269\u201382.","journal-title":"Med Phys"},{"key":"1144_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1144_CR19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.radonc.2017.05.007","volume":"123","author":"A Chi","year":"2017","unstructured":"Chi A, Chen H, Wen S, et al. Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review and hypothesis-generating meta-analysis. Radiother Oncol. 2017;123:346\u201354.","journal-title":"Radiother Oncol"},{"key":"1144_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fonc.2014.00292","volume":"4","author":"KC Wink","year":"2014","unstructured":"Wink KC, Roelofs E, Solberg T, et al. Particle therapy for non-small cell lung tumors: where do we stand? A systematic review of the literature. Front Oncol. 2014;4:292.","journal-title":"Front Oncol"},{"key":"1144_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.ijrobp.2005.04.024","volume":"63","author":"M Imura","year":"2005","unstructured":"Imura M, Yamazaki K, Shirato H, et al. Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:1442\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.ijrobp.2009.10.040","volume":"77","author":"W Wunderink","year":"2010","unstructured":"Wunderink W, Romero AM, Seppenwoolde Y, et al. Potentials and limitations of guiding liver stereotactic body radiation therapy set-up on liver-implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2010;77:1573\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejmp.2016.12.018","volume":"33","author":"S Abe","year":"2017","unstructured":"Abe S, Kubota Y, Shibuya K, et al. Fiducial marker matching versus vertebral body matching: Dosimetric impact of patient positioning in carbon ion radiotherapy for primary hepatic cancer. Phys Med. 2017;33:114\u201320.","journal-title":"Phys Med"},{"key":"1144_CR24","doi-asserted-by":"crossref","unstructured":"Sakai M, Kubota Y, Saitoh J, et al. Robustness of patient positioning for interfractional error in carbon ion radiotherapy for stage I lung cancer: bone matching versus tumor matching. Radiother Oncol. 2017; [Epub ahead of print].","DOI":"10.1016\/j.radonc.2017.10.003"},{"key":"1144_CR25","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1118\/1.3129161","volume":"36","author":"B Zhao","year":"2009","unstructured":"Zhao B, Yang Y, Li T, et al. Image-guided respiratory-gated lung stereotactic body radiotherapy: which target definition is optimal? Med Phys. 2009;36:2248\u201357.","journal-title":"Med Phys"},{"key":"1144_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijrobp.2016.01.036","volume":"95","author":"JY Chang","year":"2016","unstructured":"Chang JY, Jabbour SK, Ruysscher DD, et al. Consensus statement on proton therapy in early-stage and locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2016;95:505\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","volume":"99","author":"JY Chang","year":"2017","unstructured":"Chang JY, Zhang X, Knopf A, et al. Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee. Int J Radiat Oncol Biol Phys. 2017;99:41\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1144_CR28","doi-asserted-by":"publisher","first-page":"e94971","DOI":"10.1371\/journal.pone.0094971","volume":"9","author":"S Shimizu","year":"2014","unstructured":"Shimizu S, Miyamoto N, Matsuura T, et al. A proton beam therapy system dedicated to spot-scanning increases accuracy with moving tumors by real-time imaging and gating and reduces equipment size. PLoS One. 2014;9:e94971.","journal-title":"PLoS One"},{"key":"1144_CR29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1118\/1.3679340","volume":"39","author":"W Liu","year":"2012","unstructured":"Liu W, Zhang X, Li Y, et al. Robust optimization of intensity modulated proton therapy. Med Phys. 2012;39:1079\u201391.","journal-title":"Med Phys"},{"key":"1144_CR30","doi-asserted-by":"publisher","first-page":"i76","DOI":"10.1093\/jrr\/rrw015","volume":"57","author":"Y Shibamoto","year":"2016","unstructured":"Shibamoto Y, Miyakawa A, Otsuka S, et al. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules? J Radiat Res. 2016;57:i76\u201382.","journal-title":"J Radiat Res"},{"key":"1144_CR31","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/0284186X.2017.1348621","volume":"56","author":"R Mohan","year":"2017","unstructured":"Mohan R, Peeler CR, Guan F, et al. Radiobiological issues in proton therapy. Acta Oncol. 2017;56:1367\u201373.","journal-title":"Acta Oncol"},{"key":"1144_CR32","doi-asserted-by":"publisher","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","volume":"59","author":"H Paganetti","year":"2014","unstructured":"Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer. Phys Med Biol. 2014;59:R419\u201372.","journal-title":"Phys Med Biol"},{"key":"1144_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00066-017-1223-9","volume":"194","author":"S Hashimoto","year":"2018","unstructured":"Hashimoto S, Sugie C, Iwata H, et al. Recovery from sublethal damage and potentially lethal damage: proton-beam irradiation vs. X-ray irradiation. Strahlenther Onkol. 2018;194:343\u201351.","journal-title":"Strahlenther Onkol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1144-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1144-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1144-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T19:23:38Z","timestamp":1570735418000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1144-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1144"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1144-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]},"assertion":[{"value":"22 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The data of this study was extracted from ongoing prospective phase II clinical trials based on protocols approved by the Institutional Review Board (IRB) of Nagoya City Hospital. The IRB numbers are 13\u201302-09 (9) and 13\u201302-10 (10). Informed consent was obtained from each participant. The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written informed consent to publish the article from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"199"}}